Overview

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Study to assess symptomatic efficacy, safety and tolerability of talsaclidine in patients with mild to moderate dementia of Alzheimer type

Phase:

Phase 2

Details

Lead Sponsor:

Boehringer Ingelheim